HFQRX
Price
$8.20
Change
+$0.19 (+2.37%)
Updated
Jun 11 closing price
Net Assets
7.63B
LIDOX
Price
$11.79
Change
+$0.09 (+0.77%)
Updated
Jun 12 closing price
Net Assets
528.62M
Interact to see
Advertisement

HFQRX vs LIDOX

Header iconHFQRX vs LIDOX Comparison
Open Charts HFQRX vs LIDOXBanner chart's image
HFQRX vs LIDOX Comparison Chart in %
View a ticker or compare two or three
VS
HFQRX vs. LIDOX commentary
Jun 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HFQRX is a StrongBuy and LIDOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
HFQRX has more cash in the bank: 7.63B vs. LIDOX (529M). HFQRX pays higher dividends than LIDOX: HFQRX (6.34) vs LIDOX (2.70). HFQRX was incepted earlier than LIDOX: HFQRX (11 years) vs LIDOX (9 years). HFQRX (0.69) and LIDOX (0.66) have similar cost to investors . HFQRX is a more actively managed with annual turnover of: 175.00 vs. LIDOX (66.00). LIDOX has a lower initial minimum investment than HFQRX: LIDOX (0) vs HFQRX (1000000). HFQRX (25.65) and LIDOX (25.23) have marching annual gain over last year. HFQRX return over 5 years is better than : 67.18 vs. LIDOX (56.10).
HFQRXLIDOXHFQRX / LIDOX
Total Expense Ratio0.690.66105%
Annual Report Gross Expense Ratio0.690.66105%
Fund Existence11 years9 years-
Gain YTD13.55710.396130%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets7.63B529M1,443%
Annual Yield % from dividends6.342.70235%
Returns for 1 year25.6525.23102%
Returns for 3 years67.6075.1990%
Returns for 5 years67.1856.10120%
Returns for 10 years133.67N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MCO447.856.03
+1.36%
Moody's Corp
VLN2.21N/A
N/A
Valens Semiconductor Ltd
VCTR84.84-1.58
-1.83%
Victory Capital Holdings
APPS9.76-0.38
-3.75%
Digital Turbine
AKTX13.40-1.42
-9.58%
Akari Therapeutics Plc